Havrdova E, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Relapsing Multiple Sclerosis in the OPERA I and OPERA II Trials. EAN 2017, PR1092.
ECTRIMS 2015 video update Bouma: Parallel Session 2 New challenges in clinical trial design
jun 2017